AMPLify | Ateneo Molecular Pathology Laboratory

Ateneo de Manila University established the Ateneo Molecular Pathology Laboratory (AMPLify) in response to the nation’s call for more diagnostic facilities to help ramp up testing capacity as one way to fight the pandemic caused by the SARS-CoV-2 and all other notifiable infectious diseases.

AMPLify was granted a License to Operate (LTO) by the Department of Health-Health Facilities and Services Regulatory Bureau effective 23 March 2021. It is a laboratory with Biosafety Level 2 (BSL2) containment designed in accordance with the provisions of the World Health Organization (WHO). The facility is currently designed for the detection of SARS-CoV-2, the causative agent of COVID 19, using real time RT-PCR.

AMPLify is fully-equipped with top of the line automated machines and high quality reagents, and  manned by a group of well-trained laboratory personnel that are dedicated to COVID-19 testing.

AMPLify is under the Ateneo Research Institute of Science and Engineering which is under the School of Science and Engineering.